Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes

Melanie A Lindenberg, Valesca P Retèl, Henk G van der Poel, Ferdau Bandstra, Carl Wijburg, Wim H van Harten*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
16 Downloads (Pure)


Robot-Assisted Radical Prostatectomy (RARP) is one of the standard treatment options for prostate cancer. However, controversy still exists on its added value. Based on a recent large-sample retrospective cluster study from the Netherlands showing significantly improved long-term urinary functioning after RARP compared to Laparoscopic RP (LRP), we evaluated the cost-effectiveness of RARP compared to LRP. A decision tree was constructed to measure the costs and effects from a Dutch societal perspective over a ~ 7 year time-horizon. The input was based on the aforementioned study, including patient-reported consumption of addition care and consumed care for ergonomic issues reported by surgeons. Intervention costs were calculated using a bottom-up costing analysis in 5 hospitals. Finally, a probabilistic-, one-way sensitivity- and scenario analyses were performed to show possible decision uncertainty. The intervention costs were €9964 for RARP and €7253 for LRP. Total trajectory costs were €12,078 for RARP and €10,049 for LRP. RARP showed higher QALYs compared to LRP (6.17 vs 6.11). The incremental cost-utility ratio (ICUR) was €34,206 per QALY gained, in favour of RARP. As a best-case scenario, when RARP is being centralized (> 150 cases/year), total trajectory costs decreased to €10,377 having a higher utilization, and a shorter procedure time and length of stay resulting in an ICUR of €3495 per QALY gained. RARP showed to be cost-effective compared to LRP based on data from a population-based, large scale study with 7 years of follow-up. This is a clear incentive to fully reimburse RARP, especially when hospitals provide RARP centralized.

Original languageEnglish
Article number7658
JournalScientific Reports
Issue number1
Publication statusPublished - 10 May 2022

Bibliographical note

W.H. van Harten received funding from Intuitive surgical to continue and finish this study. The sponsor had no influence on the design of the study, the methodologies used and the results presented.

© 2022. The Author(s).


Dive into the research topics of 'Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes'. Together they form a unique fingerprint.

Cite this